X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5526) 5526
Book Review (648) 648
Publication (320) 320
Magazine Article (23) 23
Newsletter (23) 23
Book Chapter (12) 12
Newspaper Article (11) 11
Conference Proceeding (10) 10
Book / eBook (2) 2
Dissertation (2) 2
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5051) 5051
male (3105) 3105
humans (2967) 2967
animals (2846) 2846
hyperglycemia - chemically induced (2708) 2708
hyperglycemia (2535) 2535
female (1869) 1869
rats (1583) 1583
diabetes (1540) 1540
glucose (1180) 1180
insulin (1138) 1138
endocrinology & metabolism (1018) 1018
blood glucose - metabolism (999) 999
middle aged (986) 986
adult (952) 952
mice (928) 928
hypoglycemia - chemically induced (887) 887
hypoglycemic agents - therapeutic use (700) 700
blood glucose - analysis (697) 697
diabetes mellitus (693) 693
aged (665) 665
abridged index medicus (656) 656
pharmacology & pharmacy (608) 608
hyperglycemia - drug therapy (599) 599
hypoglycemic agents - adverse effects (567) 567
insulin - blood (561) 561
hyperglycemia - metabolism (559) 559
oxidative stress (542) 542
diabetes mellitus, type 2 - drug therapy (540) 540
streptozocin (537) 537
rats, wistar (502) 502
blood glucose - drug effects (487) 487
type 2 diabetes (487) 487
insulin resistance (479) 479
diabetes mellitus, experimental - chemically induced (478) 478
risk factors (476) 476
hyperglycemia - prevention & control (458) 458
hyperglycemia - blood (448) 448
hypoglycemia (441) 441
hypoglycemic agents - administration & dosage (435) 435
analysis (430) 430
time factors (428) 428
rodents (426) 426
dose-response relationship, drug (410) 410
insulin - therapeutic use (401) 401
dextrose (400) 400
care and treatment (389) 389
insulin - metabolism (388) 388
metabolism (383) 383
insulin - adverse effects (376) 376
mellitus (371) 371
disease models, animal (369) 369
research (364) 364
rats, sprague-dawley (351) 351
diabetes mellitus, type 2 - blood (348) 348
blood sugar (345) 345
insulin - administration & dosage (338) 338
diabetes mellitus, experimental - metabolism (321) 321
health aspects (318) 318
treatment outcome (312) 312
glucose - metabolism (311) 311
glucose tolerance test (307) 307
hypoglycemia - prevention & control (304) 304
hypoglycemic agents - pharmacology (300) 300
blood glucose (297) 297
adolescent (294) 294
diabetes mellitus, experimental - drug therapy (294) 294
hyperglycemia - physiopathology (288) 288
medicine, general & internal (274) 274
therapy (274) 274
physiological aspects (268) 268
physiology (268) 268
mice, inbred c57bl (267) 267
biochemistry & molecular biology (266) 266
expression (261) 261
risk (255) 255
hyperglycemia - complications (251) 251
insulin-resistance (251) 251
glucose metabolism (250) 250
obesity (248) 248
liver (247) 247
diabetes mellitus - chemically induced (244) 244
diabetes mellitus, type 1 - drug therapy (242) 242
diabetes-mellitus (241) 241
retrospective studies (234) 234
medicine, research & experimental (231) 231
inflammation (230) 230
glycated hemoglobin a - analysis (226) 226
diabetes therapy (225) 225
glycemic control (225) 225
liver - metabolism (225) 225
mortality (225) 225
management (223) 223
cell biology (220) 220
internal medicine (218) 218
apoptosis (216) 216
insulin secretion (213) 213
neurosciences (212) 212
liver - drug effects (209) 209
article (208) 208
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5192) 5192
French (116) 116
German (80) 80
Russian (48) 48
Spanish (31) 31
Japanese (27) 27
Italian (23) 23
Polish (16) 16
Chinese (13) 13
Portuguese (9) 9
Romanian (8) 8
Bulgarian (4) 4
Czech (4) 4
Dutch (4) 4
Finnish (3) 3
Hungarian (3) 3
Norwegian (3) 3
Slovak (2) 2
Swedish (2) 2
Ukrainian (2) 2
Afrikaans (1) 1
Danish (1) 1
Hebrew (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes, ISSN 0012-1797, 01/2017, Volume 66, Issue 1, pp. 45 - 57
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Infection - chemically induced | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 770 - 778
Summary Background Pancreatic cancer statistics are dismal, with a 5-year survival of less than 10%, and more than 50% of patients presenting with metastatic... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | MITOCHONDRIAL METABOLISM | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Sulfides - administration & dosage | Pancreatic Neoplasms - drug therapy | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Hyperglycemia - chemically induced | Leucovorin - adverse effects | Fluorouracil - adverse effects | Hypokalemia - chemically induced | Camptothecin - administration & dosage | Female | Neutropenia - chemically induced | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Hematologic Diseases - chemically induced | Sensation Disorders - chemically induced | Abdominal Pain - chemically induced | Pancreatic Neoplasms - pathology | Anemia - chemically induced | Thrombocytopenia - chemically induced | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Hypoalbuminemia - chemically induced | Maximum Tolerated Dose | Sepsis - chemically induced | Sulfides - adverse effects | Aged | Caprylates - administration & dosage | Caprylates - adverse effects | Organoplatinum Compounds - adverse effects | Lymphopenia - chemically induced | Enzymes | Medical colleges | Care and treatment | Metastasis | Antineoplastic agents | Cells | Antimitotic agents | Cancer patients | Chemotherapy | Pancreatic cancer | Physiological aspects | Product development | Cancer | Index Medicus
Journal Article
Pathology & Oncology Research, ISSN 1219-4956, 12/2011, Volume 17, Issue 4, pp. 887 - 892
Journal Article
International Journal of Biological Macromolecules, ISSN 0141-8130, 03/2019, Volume 124, pp. 377 - 388
Fucosylated chondroitin sulfate from (fCS- ) is a kind of sulfated polysaccharides with well-repeated structure. In our former publications, fCS- has been... 
Gut microbiota | Metabolic syndromes | Fucosylated chondroitin sulfate from sea cucumber | High-fat and high-sucrose diet | ACTIVATION | POLYMER SCIENCE | BIOCHEMISTRY & MOLECULAR BIOLOGY | cumber | ANTICOAGULANT | OBESITY | SEA-CUCUMBER | LIVER | LOW-GRADE INFLAMMATION | CHEMISTRY, APPLIED | EXPRESSION | ANTITHROMBOTIC ACTIVITIES | POLYSACCHARIDE | Hypertrophy - chemically induced | Inflammation - chemically induced | Sea Cucumbers - chemistry | Inflammation - pathology | Dysbiosis - drug therapy | Obesity - drug therapy | Fatty Liver - pathology | Humans | Diet, High-Fat - adverse effects | Adipocytes - drug effects | Dysbiosis - microbiology | Fatty Liver - chemically induced | Hypertrophy - pathology | Metabolic Syndrome - chemically induced | Hyperglycemia - drug therapy | Metabolic Syndrome - drug therapy | Hyperglycemia - chemically induced | Inflammation - drug therapy | Hyperglycemia - pathology | Dysbiosis - chemically induced | Fructose - adverse effects | Obesity - chemically induced | Hyperlipidemias - drug therapy | Chondroitin Sulfates - isolation & purification | Chondroitin Sulfates - chemistry | Adipocytes - pathology | Fatty Liver - drug therapy | Obesity - pathology | Chondroitin Sulfates - administration & dosage | Animals | Gastrointestinal Microbiome - drug effects | Hyperlipidemias - pathology | Mice | Metabolic Syndrome - pathology | Hyperlipidemias - chemically induced | Hypertrophy - drug therapy | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 76, pp. 36 - 44
Abstract Background The phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt) signalling axis and androgen receptor (AR) pathways exhibit reciprocal... 
Hematology, Oncology and Palliative Medicine | Dactolisib (BEZ235) | Castration-resistant prostate cancer (CRPC) | Buparlisib (BKM120) | Abiraterone acetate (AA) | SURVIVAL | MANAGEMENT | PI3K | ONCOLOGY | Buparlisib (BKM 120) | CHEMOTHERAPY | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Area Under Curve | Humans | Middle Aged | Aminopyridines - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Imidazoles - administration & dosage | Male | Imidazoles - pharmacokinetics | Diarrhea - chemically induced | Quinolines - administration & dosage | Fever - chemically induced | Quinolines - pharmacokinetics | Chills - chemically induced | Abiraterone Acetate - administration & dosage | Hyperglycemia - chemically induced | Aged, 80 and over | Kallikreins - blood | Abiraterone Acetate - pharmacokinetics | Aminopyridines - administration & dosage | Prostatic Neoplasms, Castration-Resistant - blood | Morpholines - administration & dosage | Prostatic Neoplasms, Castration-Resistant - drug therapy | Prostate-Specific Antigen - blood | Asthenia - chemically induced | Vomiting - chemically induced | Maximum Tolerated Dose | Stomatitis - chemically induced | Aged | Morpholines - pharmacokinetics | TOR protein | Slopes | Toxicity | Prostate-specific antigen | Oncology | Homology | AKT protein | Metastases | Anticancer properties | Proteins | Chills | Signal transduction | Hyperglycemia | Occupational safety | Castration | Vomiting | Safety | Tensin | Medical treatment | Diarrhea | Pharmacology | Rapamycin | Prednisone | Patients | Fever | 1-Phosphatidylinositol 3-kinase | Androgens | Stomatitis | Inhibitors | Asthenia | Pharmacokinetics | Acetic acid | Human behavior | Prostate cancer | Prostate | PTEN protein | Cancer | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 01/2008, Volume 111, Issue 2, pp. 566 - 573
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 654 - 662
Journal Article
Journal Article